share_log

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

ADC 治療學預計截至 2022 年 12 月 31 日止三個月的產品淨收入將約為 19.8 億美元;預計截至 2022 年 12 月 31 日,現金和現金等價物將約為 326.4 億美元
Benzinga Real-time News ·  2023/02/02 06:34

ADC Therapeutics Expects That Product Revenues, Net, Will Be About $19.8M For Three Months Ended Dec. 31, 2022; Expects Cash And Cash Equivalents Will Be About $326.4M As Of Dec. 31, 2022

ADC 治療學預計截至 2022 年 12 月 31 日止三個月的產品淨收入將約為 19.8 億美元;預計截至 2022 年 12 月 31 日,現金和現金等價物將約為 326.4 億美元

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論